MHRA approves olezarsen (Tryngolza) for the treatment of familial chylomicronemia syndrome The Medicines and Healthcare products Regulatory Agency ...
In a bar, a poet meets the man behind the drug that saved his life — discovering how science, faith and chance created a future thought impossible.
More than a quarter of people with Type 2 diabetes take GLP-1 receptor agonists, but the popular diabetes drugs might not work as well for people who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results